Shareholders' Equity (Tables)
|
6 Months Ended |
Jun. 30, 2017 |
| Shareholders' Equity [Abstract] |
|
| Schedule of key assumptions used model at inception |
| | | Inception | | 1/30/2017 | | | | | | | | Stock Price | | $0.00 - $60.00 | | $0.00 - $6.20 | | Exercise Price | | $22.40 | | $22.40 | | Term | | .5 years | | 0.72 to 0.83 years | | Risk Free Interest Rate | | .39% - .47% | | 0.81% | | Volatility | | 60% | | 60% | | Dividend Rate | | 0% | | 0% |
|
| Schedule of shortfall provision derivative liability |
| Balance – December 31, 2016 | | $ | 2,093,623 | | | Fair Value Adjustment | | | 844,112 | | | Extinguishment of Liability | | | (2,937,735 | ) | | Balance – June 30, 2017 | | $ | - |
|
| Schedule of outstanding stock warrants |
| | | Number of Shares | | | Average Exercise Price | | | If exercised | | Expiration Date | | Outstanding - December 31, 2016 | | | 148,777 | | | $ | 3.02 | | | | | | | Granted – January 30, 2017 | | | 3,112,871 | | | | 5.16 | | | | | January 31, 2022 | | Granted – June 30, 2017 | | | 575,000 | | | | 1.90 | | | | | | | Granted – June 30, 2017 | | | 100,000 | | | | 2.19 | | | | | | | Exercised | | | 148,777 | | | | | | | | | | | Outstanding, March 31, 2017 | | | 3,787,871 | | | $ | 4.59 | | | | | | | Warrants exercisable at March 31, 2017 | | | 3,787,871 | | | | | | | | | |
|
| Schedule of the company's stock options |
| | | Number of Shares Underlying Options | | | Weighted Average Exercise Price | | | Weighted Average Grant Date Fair Value | | | Weighted Average Remaining Contractual Life | | | Aggregate Intrinsic Value (1) | | | | | | | | | | | | | | | | | | | | Outstanding at December 31, 2016 | | | 12,250 | | | $ | 19.35 | | | $ | 4.78 | | | | 4.84 | | | | - | | | | | | | | | | | | | | | | | | | | | | | | | For the six months ended June 30, 2017 | | | | | | | | | | | | | | | | | | | | | | Granted | | | - | | | | - | | | | - | | | | - | | | | | | | Exercised | | | - | | | | - | | | | - | | | | - | | | | | | | Expired | | | - | | | | - | | | | - | | | | - | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Outstanding at June 30, 2017 | | | 12,250 | | | $ | 19.35 | | | $ | 4.78 | | | | 4.35 | | | | - | | | | | | | | | | | | | | | | | | | | | | | | | Outstanding and Exercisable at June 30, 2017 | | | 2,722 | | | $ | 19.35 | | | $ | 4.78 | | | | 4.35 | | | | - | |
| (1) | The aggregate intrinsic value is based on the $1.65 closing price as of June 30, 2017 for the Company’s Common Stock. |
|
| Schedule of following information applies to options outstanding |
| Options Outstanding | | Options Exercisable | | | Exercise Price | | Number of Shares Underlying Options | | | Weighted Average Remaining Contractual Life | | | Number Exercisable | | | Exercise Price | | | $12.00 | | | 1,000 | | | | 4.35 | | | | 222 | | | $ | 12.00 | | | $20.00 | | | 11,250 | | | | 4.35 | | | | 2,500 | | | $ | 20.00 | | | | | | 12,250 | | | | 4.35 | | | | 2,722 | |
|